Simone Nardin
Impact in
-
- Cancer survivorship and care
- Cancer Immunotherapy and Biomarkers
- HER2/EGFR in Cancer Research
-
- Breast Cancer Treatment Studies
Papers in
-
- Breast Cancer Treatment Studies 9
- Oncology 9
- Cancer Treatment and Pharmacology 3
- HER2/EGFR in Cancer Research 3
- Cancer Immunotherapy and Biomarkers 2
- Cancer survivorship and care 2
- Co-authors
- Valentina Rossi (2 shared papers)Francesca D’Avanzo (2 shared papers)Alessandra Gennari (3 shared papers)Sara Rubinelli (1 shared paper)Chiara Saggia (1 shared paper)Matteo Nardin (6 shared papers)Matteo Pagnesi (2 shared papers)Chiara Pirrone (1 shared paper)
In The Last Decade
Simone Nardin
25 papers receiving 415 citations
Peers
Comparison fields: 5 of 71
- Oncology 163
- Cancer Research 61
- Pathology and Forensic Medicine 32
- Pulmonary and Respiratory Medicine 46
- Radiology, Nuclear Medicine and Imaging 28
Countries citing papers authored by Simone Nardin
This map shows the geographic impact of Simone Nardin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Simone Nardin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Simone Nardin more than expected).
Fields of papers citing papers by Simone Nardin
This network shows the impact of papers produced by Simone Nardin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Simone Nardin. The network helps show where Simone Nardin may publish in the future.
Co-authors
The 25 scholars most cited alongside Simone Nardin, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 29 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2020 | 238 | |
| 2 | 2023 | 34 | |
| 3 | 2023 | 26 | |
| 4 | 2024 | 22 | |
| 5 | 2024 | 21 | |
| 6 | 2023 | 12 | |
| 7 | 2023 | 10 | |
| 8 | 2025 | 9 | |
| 9 | 2023 | 5 | |
| 10 | 2024 | 5 | |
| 11 | 2025 | 5 | |
| 12 | 2025 | 5 | |
| 13 | 2023 | 4 | |
| 14 | 2025 | 4 | |
| 15 | 2025 | 4 | |
| 16 | 2025 | 4 | |
| 17 | 2024 | 3 | |
| 18 | 2024 | 3 | |
| 19 | 2023 | 2 | |
| 20 | 2024 | 2 |
About Simone Nardin
Simone Nardin is a scholar working on Cancer Research, Oncology, Pulmonary and Respiratory Medicine, Public Health, Environmental and Occupational Health and Pathology and Forensic Medicine, having authored 29 papers that have together received 424 indexed citations. Recurring topics across this work include Breast Cancer Treatment Studies (9 papers), Advanced Breast Cancer Therapies (4 papers), Lung Cancer Treatments and Mutations (3 papers), Cancer Treatment and Pharmacology (3 papers), HER2/EGFR in Cancer Research (3 papers), Cancer Immunotherapy and Biomarkers (2 papers), Cancer survivorship and care (2 papers) and Palliative and Oncologic Care (2 papers). The work is most often cited by research in Oncology (163 citations), Cancer Research (61 citations), Pathology and Forensic Medicine (32 citations), Pulmonary and Respiratory Medicine (46 citations) and Radiology, Nuclear Medicine and Imaging (28 citations). Simone Nardin has collaborated with scholars based in Italy, Belgium and Austria. Frequent co-authors include Valentina Rossi, Francesca D’Avanzo, Alessandra Gennari, Sara Rubinelli, Chiara Saggia, Matteo Nardin, Matteo Pagnesi, Chiara Pirrone, Stefania Sciallero and Andreas Seeber. Their work appears in journals such as ESMO Open, Frontiers in Oncology, Expert Opinion on Pharmacotherapy, Cancers and Journal of Clinical Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.